IVABRADINE 7.5 Milligram Film Coated Tablet আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

ivabradine 7.5 milligram film coated tablet

clonmel healthcare ltd - ivabradine - film coated tablet - 7.5 milligram - other cardiac preparations

CORLANOR- ivabradine tablet, film coated
CORLANOR- ivabradine solution মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

corlanor- ivabradine tablet, film coated corlanor- ivabradine solution

amgen inc - ivabradine hydrochloride (unii: tp19837bzk) (ivabradine - unii:3h48l0lpzq) - ivabradine 5 mg - corlanor is indicated to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with left ventricular ejection fraction ≤ 35%, who are in sinus rhythm with resting heart rate ≥ 70 beats per minute and either are on maximally tolerated doses of beta-blockers or have a contraindication to beta-blocker use.  corlanor is indicated for the treatment of stable symptomatic heart failure due to dilated cardiomyopathy (dcm) in pediatric patients aged 6 months and older, who are in sinus rhythm with an elevated heart rate. corlanor is contraindicated in patients with: • acute decompensated heart failure • clinically significant hypotension • sick sinus syndrome, sinoatrial block or 3rd degree av block, unless a functioning demand pacemaker is present • clinically significant bradycardia [see warnings and precautions ( 5.3 )] • severe hepatic impairment [see use in specific populations ( 8.6 )] • pacemaker dependence (heart rate maintained exclu

APO-FENTANYL fentanyl 12 micrograms/hour transdermal drug delivery system sachet অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

apo-fentanyl fentanyl 12 micrograms/hour transdermal drug delivery system sachet

sandoz pty ltd - fentanyl, quantity: 2.1 mg - drug delivery system, transdermal - excipient ingredients: polyethylene terephthalate; ethyl acetate; 2-ethylhexyl acrylate; vinyl acetate; 2,2'-azobisisobutyronitrile; 2-hydroxyethyl acrylate - for the management of pain associated with cancer, palliative cancer and other conditions in patients where: - other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and - the pain is opioid-responsive, and - severe enough to require daily, continuous long term opioid treatment. not for use in opioid-naive patients.

FENTANYL SANDOZ fentanyl 100 micrograms/hour transdermal drug delivery system sachet অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

fentanyl sandoz fentanyl 100 micrograms/hour transdermal drug delivery system sachet

sandoz pty ltd - fentanyl, quantity: 16.8 mg - drug delivery system, transdermal - excipient ingredients: polyethylene terephthalate; ethyl acetate; 2-ethylhexyl acrylate; vinyl acetate; 2,2'-azobisisobutyronitrile; 2-hydroxyethyl acrylate - for the management of pain associated with cancer, palliative cancer and other conditions in patients where: - other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and - the pain is opioid-responsive, and - severe enough to require daily, continuous long term opioid treatment. not for use in opioid-naive patients.

APO-FENTANYL fentanyl 100 micrograms/hour transdermal drug delivery system sachet অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

apo-fentanyl fentanyl 100 micrograms/hour transdermal drug delivery system sachet

sandoz pty ltd - fentanyl, quantity: 16.8 mg - drug delivery system, transdermal - excipient ingredients: polyethylene terephthalate; ethyl acetate; 2-ethylhexyl acrylate; vinyl acetate; 2,2'-azobisisobutyronitrile; 2-hydroxyethyl acrylate - for the management of pain associated with cancer, palliative cancer and other conditions in patients where: - other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and - the pain is opioid-responsive, and - severe enough to require daily, continuous long term opioid treatment. not for use in opioid-naive patients.

APO-FENTANYL fentanyl 25 micrograms/hour transdermal drug delivery system sachet অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

apo-fentanyl fentanyl 25 micrograms/hour transdermal drug delivery system sachet

sandoz pty ltd - fentanyl, quantity: 4.2 mg - drug delivery system, transdermal - excipient ingredients: polyethylene terephthalate; ethyl acetate; 2-ethylhexyl acrylate; vinyl acetate; 2,2'-azobisisobutyronitrile; 2-hydroxyethyl acrylate - for the management of pain associated with cancer, palliative cancer and other conditions in patients where: - other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and - the pain is opioid-responsive, and - severe enough to require daily, continuous long term opioid treatment. not for use in opioid-naive patients.

APO-FENTANYL fentanyl 50 micrograms/hour transdermal drug delivery system sachet অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

apo-fentanyl fentanyl 50 micrograms/hour transdermal drug delivery system sachet

sandoz pty ltd - fentanyl, quantity: 8.4 mg - drug delivery system, transdermal - excipient ingredients: polyethylene terephthalate; ethyl acetate; 2-ethylhexyl acrylate; vinyl acetate; 2,2'-azobisisobutyronitrile; 2-hydroxyethyl acrylate - for the management of pain associated with cancer, palliative cancer and other conditions in patients where: - other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and - the pain is opioid-responsive, and - severe enough to require daily, continuous long term opioid treatment. not for use in opioid-naive patients.

FENTANYL SANDOZ fentanyl 12 micrograms/hour transdermal drug delivery system sachet অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

fentanyl sandoz fentanyl 12 micrograms/hour transdermal drug delivery system sachet

sandoz pty ltd - fentanyl, quantity: 2.1 mg - drug delivery system, transdermal - excipient ingredients: polyethylene terephthalate; ethyl acetate; 2-ethylhexyl acrylate; vinyl acetate; 2,2'-azobisisobutyronitrile; 2-hydroxyethyl acrylate - for the management of pain associated with cancer, palliative cancer and other conditions in patients where: - other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and - the pain is opioid-responsive, and - severe enough to require daily, continuous long term opioid treatment. not for use in opioid-naive patients.

FENTANYL SANDOZ fentanyl 50 micrograms/hour transdermal drug delivery system sachet অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

fentanyl sandoz fentanyl 50 micrograms/hour transdermal drug delivery system sachet

sandoz pty ltd - fentanyl, quantity: 8.4 mg - drug delivery system, transdermal - excipient ingredients: polyethylene terephthalate; ethyl acetate; 2-ethylhexyl acrylate; vinyl acetate; 2,2'-azobisisobutyronitrile; 2-hydroxyethyl acrylate - for the management of pain associated with cancer, palliative cancer and other conditions in patients where: - other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and - the pain is opioid-responsive, and - severe enough to require daily, continuous long term opioid treatment. not for use in opioid-naive patients.

APO-FENTANYL fentanyl 75 micrograms/hour transdermal drug delivery system sachet অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

apo-fentanyl fentanyl 75 micrograms/hour transdermal drug delivery system sachet

sandoz pty ltd - fentanyl, quantity: 12.6 mg - drug delivery system, transdermal - excipient ingredients: polyethylene terephthalate; ethyl acetate; 2-ethylhexyl acrylate; vinyl acetate; 2,2'-azobisisobutyronitrile; 2-hydroxyethyl acrylate - for the management of pain associated with cancer, palliative cancer and other conditions in patients where: - other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and - the pain is opioid-responsive, and - severe enough to require daily, continuous long term opioid treatment. not for use in opioid-naive patients.